Definitive Contract 75D30121C10168
Award Date
1/1/21
Potential Completion Date
12/31/30
Potential Value
$9.9M
Federal Agency
CDC Pittsburgh
Ultimate Awardee
State Of South Carolina
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
South Africa
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
22
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $1,434,867.00 definitive cost-no-fee contract to The Johns Hopkins University to support the Tuberculosis Trials Consortium (TBTC). This contract, which does not have a set-aside designation, was awarded on September 18, 2019 and has a completion date of March 17, 2021. The Johns Hopkins University, a private non-profit research university, will provide clinical trial and data coordination services...
This is a $13,523,501.30 definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to The Research Institute Of The Mcgill University Health Centre for Tuberculosis Trials Consortium Services. The contract has a period of performance through December 31, 2030 and was awarded on January 1, 2021. It is a cost-no-fee contract to support clinical trials and research on the treatment, diagnosis, and prevention of tuberculosis, including studies of latent TB infection in...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a Definitive Contract to The Trustees of Columbia University in the City of New York Sponsored Projects Administration Division (Columbia University) for the TUBERCULOSIS TRIALS CONSORTIUM (TBTC) project. The contract has a potential value of $523,857.39 and is a Cost No Fee type contract. The contract does not have a set-aside designation and was awarded on September 18, 2019 with a completion date of...
Duke University, as prime contractor, was awarded a $4.3 million delivery order against the Tuberculosis Epidemiology Studies Consortium master IDIQ by the Centers for Disease Control and Prevention. The contract calls for enrollment, preventive treatment, data collection and analysis of latent tuberculosis infection patients. Major subcontractors include Atrium Health and Vanderbilt University, which will assist with performance of the clinical work. The goal of the project appears to be...
This is a definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Case Western Reserve University's Office of Research Administration Division, doing business as University Hospitals of Cleveland, with a ceiling value of $15,729,937.34. The contract is for tuberculosis trials and consortium services over a 10-year period of performance from January 1, 2021 to December 31, 2030. There is no set-aside designation for this award. The contract requires the vendor to...
The Centers for Disease Control and Prevention awarded a $154,876 delivery order contract to The Trustees of Columbia University in New York, New York. The contract supports research entitled "TB in the U.S.: Epidemiology and Prevention Opportunities" through September 14, 2010. As a private, non-profit educational institution, Columbia University will provide subject matter expertise and analysis to the CDC regarding tuberculosis trends, transmission dynamics, and strategies for...
The Centers for Disease Control and Prevention (CDC) awarded a $4,455,976 cost-no-fee definitive contract to The Regents of the University of California, San Francisco (UCSF) to develop, implement, and evaluate interventions to improve latent tuberculosis infection (LTBI) identification and treatment among high-risk non-U.S.-born populations in primary care settings. This contract, known as Tuberculosis Epidemiologic Studies Consortium III (TBESC3), has a period of performance from September 29,...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $1,724,262 definitive cost-no-fee contract to The Regents of the University of California, San Francisco (UCSF) for the Tuberculosis Trials Consortium. The contract has a completion date of December 31, 2021 and is not set aside for any special program. UCSF is an academic institution that has previously received federal contracts and grants from agencies such as the National Institutes of Health,...
Columbia University has been awarded a $3,145,990 delivery order against its $999,990 Other Transaction Agreement with the Centers for Disease Control and Prevention (CDC). The delivery order is for the TBES Consortium to provide research and development services in support of CDC's disease prevention and health promotion objectives. As part of its Other Transaction Agreement vehicle, Columbia University conducts scientific studies for CDC on topics such as infectious diseases, chronic...
This is a $445,000.00 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to the University of Cape Town (UCT) in South Africa. The contract supports the PREDICT-TB and NEXGEN clinical trials, which are focused on tuberculosis research and development. UCT, a major research institution in South Africa, has extensive expertise in infectious disease research and...